-DNA The Bombay High Court has stayed an order passed by the State Information Commission (SIC) which stated that Reliance Infrastructure Ltd (R-Infra), the Anil Ambani-led company, is also covered under the Right to Information (RTI) Act. A division bench of Justice BH Marlapalle and Justice Nishita Mhatre granted an interim stay and directed the government to file a reply in eight weeks while hearing an appeal filed by R-Infra against the...
More »SEARCH RESULT
Dangerous culture of intolerance
-The Hindu It speaks to the deeply divisive times we live in that Team Anna activist and Supreme Court lawyer Prashant Bhushan was savagely assaulted in his own chamber — and in the full glare of television cameras — for the “crime” of saying something that his attackers disapproved of. In the past, intolerant groups who seem to have no problem breaking the law with impunity, have targeted writers, artists, journalists,...
More »Labour, supply issues halt production at Maruti Suzuki
-IANS Production at automobile giant Maruti Suzuki's Gurgaon plant came to a halt Friday due to lack of components supply following labour unrest at the company's other plants, including the Manesar facility. 'Production has been stopped at the Gurgaon plant due to lack of component supply. Production at Manesar plant and component supply units remained closed due to the strike,' a senior company official told IANS. According to the official, the company on...
More »SC asks courts to view labour practices in changed economic context by Sanjay K Singh
The Supreme Court has asked the judiciary and statutory bodies to take into account objectives of industrial peace and economic justice while deciding on disputes related to unfair labour practices. The issue of unfair labour practice has to be decided in the changed circumstances of economic liberalisation and economic reforms, the court said, setting aside the Bombay High Court order against Siemens. "Today every state, which has to don the mantle of...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »